Ruthenium (II)-derived organometallic compounds induce cytostatic and cytotoxic effects on mammalian cancer cell lines through p53-dependent and p53-independent mechanisms.

Source:http://linkedlifedata.com/resource/pubmed/id/16169939

Download in:

View as

General Info

PMID
16169939